
Personalis PSNL
€ 7.36
5.86%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Personalis Langfristiger Schuldenstrom 2011-2026 | PSNL
Langfristiger Schuldenstrom Jährlich Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.7 M | 7.76 M | 5.39 M | 3.73 M | 2.44 M | 1.36 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.76 M | 1.36 M | 4.73 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 24.59 | 6.4 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 39.6 | 0.66 % | $ 1.1 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
DexCom
DXCM
|
21.1 M | $ 70.7 | 4.9 % | $ 27.3 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Co-Diagnostics
CODX
|
838 K | $ 6.01 | -2.91 % | $ 176 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
29.2 M | $ 104.68 | -4.98 % | $ 12.8 B | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.6 | 0.95 % | $ 2.03 M | ||
|
Illumina
ILMN
|
79 M | $ 143.1 | 1.44 % | $ 22.8 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
IQVIA Holdings
IQV
|
99 M | $ 239.3 | -1.3 % | $ 43.4 B | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
1.87 M | $ 66.68 | -1.3 % | $ 4.61 B | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
23.3 M | $ 599.14 | 0.7 % | $ 18.5 B | ||
|
CareDx, Inc
CDNA
|
5.94 M | $ 20.14 | 17.57 % | $ 1.08 B | ||
|
Danaher Corporation
DHR
|
173 M | $ 237.36 | -0.42 % | $ 174 B | ||
|
Celcuity
CELC
|
172 K | $ 103.34 | -3.88 % | $ 4.08 B | ||
|
ENDRA Life Sciences
NDRA
|
96.9 K | $ 4.52 | -2.8 % | $ 2.43 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
2.68 M | $ 19.91 | 0.96 % | $ 489 M | ||
|
Natera
NTRA
|
7.64 M | $ 233.53 | -0.34 % | $ 23 B | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 12.0 | -1.32 % | $ 340 M | ||
|
Anixa Biosciences
ANIX
|
29 K | $ 3.15 | -6.81 % | $ 100 K | ||
|
Pacific Biosciences of California
PACB
|
9.59 M | $ 1.98 | 2.06 % | $ 502 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 29.88 | 1.1 % | $ 20 B | ||
|
Exact Sciences Corporation
EXAS
|
27.4 M | $ 102.08 | -0.03 % | $ 18.9 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | $ 47.69 | -1.25 % | $ 10.6 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 28.02 | 0.61 % | $ 847 M | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
Charles River Laboratories International
CRL
|
54.2 M | $ 215.18 | -2.67 % | $ 11.1 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
29.8 M | $ 1 478.38 | -0.47 % | $ 31.4 B | ||
|
Thermo Fisher Scientific
TMO
|
261 M | $ 610.0 | -1.44 % | $ 233 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.09 | -5.56 % | $ 1.97 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 38.47 | 8.92 % | $ 2.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
173 M | $ 173.92 | -0.3 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
719 K | $ 8.15 | 49.32 % | $ 1.06 B |